Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Michael S. Weiss FBIO Fortress Biotech, Inc. 13D/A 7.6% 2y
Samsara BioCapital, L.P. CRGX CARGO Therapeutics, Inc. Common Stock 13G 10.7% 2y
Lindsay A. Rosenwald, M.D. FBIO Fortress Biotech, Inc. 13D/A 17.5% 2y
Nextech VII Oncology SCSp CRGX CARGO Therapeutics, Inc. Common Stock 13G 6.8% 2y
Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust PROP Prairie Operating Co. 13D 25% 2y
STILWELL JOSEPH KWY KINGSWAY Corp 13D/A 26.9% 2y
Ningbo Shiwei Enterprise Management Partnership (L.P.) CCG Cheche Group Inc. 13G 6.5% 2y
JAT Capital Mgmt LP NXH Neighborhood Intelligence, Inc. 13D/A 9.6% 2y
BIOTECHNOLOGY VALUE FUND L P MOLN Molecular Partners AG 13D 23.9% 2y
PERCEPTIVE ADVISORS LLC VBIV VBI Vaccines, Inc. New Common Stock (Canada) 13D/A 5.8% 2y
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 12.33% 2y
ICAHN CARL C CCK Crown Holdings, Inc. 13D/A 4.99% 2y
Access Industries Holdings LLC GMDA Gamida Cell Ltd. Ordinary Shares 13D/A 1.9% 2y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 14.22% 2y
SL Globetrotter, L.P. GB Global Blue Group Holding AG 13D/A 74.4% 2y
ORBIMED ADVISORS LLC APLM Apollomics Inc. 13D/A 10.7% 2y
Cox Investment Holdings, Inc. UP Wheels Up Experience Inc. 13D/A 12.4% 2y
Brian McNulty, Individually and as Trustee of the Bay Shore Trust MIRA Mira Pharmaceuticals, Inc. 13D/A 32.45% 2y
Edward S. Lampert SRG Seritage Growth Properties 13D/A 26.5% 2y
Temasek Holdings (Private) Ltd INTA Intapp, Inc. 13D/A 24.6% 2y
Red Tree GP, LLC CRGX CARGO Therapeutics, Inc. Common Stock 13G 6.4% 2y
Saba Capital Management, L.P. BHV Blackrock Virginia Municipal Bond Trust 13D 5.72% 2y
Saba Capital Management, L.P. NBH Neuberger Municipal Fund Inc. 13D 5.25% 2y
Point72 Asset Management, L.P. CLDX Celldex Therapeutics, Inc. 13G 6.6% 2y
ADAGE CAPITAL PARTNERS GP, L.L.C. AEVA Aeva Technologies, Inc. 13G 6.23% 2y
Phoenix Financial Ltd. ARKO ARKO Corp. 13G 5.34% 2y
BROWN CAPITAL MANAGEMENT LLC PRO Pros Holdings, Inc. 13G/A 4.19% 2y
BAILLIE GIFFORD & CO ILMN Illumina, Inc. 13G/A 5.44% 2y
Rithm Capital Corp. SCU Sculptor Capital Management, Inc. Class A Common Stock 13D/A 100% 3y
Thomas J. Herzfeld Advisors, Inc. DMA Destra Multi-Alternative Fund 13G 10.03% 3y
GENERAL ATLANTIC, L.P. HRT HireRight Holdings Corporation 13D/A 47.5% 3y
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN BB BLACKBERRY Ltd 13D/A 11.8% 3y
PERCEPTIVE ADVISORS LLC NAUT Nautilus Biotechnology, Inc. 13D/A 10.1% 3y
CK Wheels LLC UP Wheels Up Experience Inc. 13D/A 37.1% 3y
PURA VIDA INVESTMENTS, LLC CUTR Cutera, Inc. 13D/A 6.62% 3y
Wengen Alberta, LP LAUR Laureate Education, Inc. 13D/A 12.22% 3y
Howard S. Jonas GNE Genie Energy Ltd. 13D/A 16.6% 3y
WILLIS CHARLES F IV WLFC Willis Lease Finance Corp 13D/A 45.09% 3y
BIOTECHNOLOGY VALUE FUND L P RPTX Repare Therapeutics Inc. Common Shares 13D/A 24.5% 3y
RA CAPITAL MANAGEMENT, L.P. CLYM Climb Bio, Inc. 13D/A 47.7% 3y
Rubric Capital Management LP TXMD TherapeuticsMD, Inc. 13D/A 25.73% 3y
Independence Energy Aggregator L.P. CRGY Crescent Energy Co 13D/A 36.3% 3y
PAG Castle Holdings Pte. Ltd. LX LexinFintech Holdings Ltd. 13D/A 4.9% 3y
CMLS Holdings LLC WGS GeneDx Holdings Corp. 13D/A 13.9% 3y
DELTA AIR LINES, INC. UP Wheels Up Experience Inc. 13D/A 37.8% 3y
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 18.89% 3y
Versant Venture Capital VI, L.P. LENZ LENZ Therapeutics, Inc. 13D/A 25.4% 3y
Andrew D. Wingate, Lucinda Falk and Zena Tamler, not individually, but solely as co-trustees of DJPS P.G. Trust. H Hyatt Hotels Corp 13D/A 5.3% 3y
Allied Physicians of California, a Professional Medical Corporation ASTH Astrana Health, Inc. 13D/A 12.9% 3y
Sylebra Capital Ltd PI Impinj Inc 13D/A 14.9% 3y